Publicaciones en colaboración con investigadores/as de Gustave Roussy Cancer Campus (3)

2023

  1. Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple Myeloma

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 23, Núm. 1, pp. e59-e70

2012

  1. Phase i studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia

    Investigational New Drugs, Vol. 30, Núm. 3, pp. 1121-1131

2007

  1. The emerging role of targeted therapy for hematologic malignancies: Update on bortezomib and tipifarnib

    Oncologist, Vol. 12, Núm. 3, pp. 281-290